NeueHealth Financials
| NEUE Stock | 5.14 0.48 10.30% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.75 | 0.9 |
|
|
The essential information of the day-to-day investment outlook for NeueHealth includes many different criteria found on its balance sheet. An individual investor should monitor NeueHealth's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in NeueHealth.
Net Income |
|
NeueHealth | Select Account or Indicator |
Please note, the presentation of NeueHealth's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, NeueHealth's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of NeueHealth's management manipulating its earnings.
NeueHealth Stock Summary
NeueHealth competes with Afya, IDP Education, Adtalem Global, and Strategic Education. NeueHealth is entity of United States. It is traded as Stock on NYSE exchange.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | USA Stock View All |
| Exchange | New York Stock Exchange |
| ISIN | US10920V4041 |
| CUSIP | 10920V107 10920V404 |
| Location | Minnesota; U.S.A |
| Business Address | 9250 NW 36th |
| Sector | Health Care Providers & Services |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.neuehealth.com |
| Phone | 612 238 1321 |
NeueHealth Key Financial Ratios
| Return On Equity | -1.83 | ||||
| Profit Margin | (0.36) % | ||||
| Operating Margin | (0.07) % | ||||
| Price To Sales | 0.04 X | ||||
| Revenue | 1.16 B |
NeueHealth Key Balance Sheet Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Assets | 1.8B | 3.6B | 4.7B | 1.2B | 1.4B | 2.7B | |
| Other Current Liab | 223.6M | 1.8B | 3.4B | 910.5M | 1.0B | 1.4B | |
| Net Debt | (460.0M) | (134.3M) | 86.9M | 283.0M | 325.5M | 341.8M | |
| Retained Earnings | (516.0M) | (1.7B) | (3.2B) | (4.3B) | (3.9B) | (3.7B) | |
| Accounts Payable | 307.0M | 321.1M | 23.4M | 169.7M | 152.8M | 136.9M | |
| Cash | 488.4M | 289.3M | 217.0M | 87.3M | 78.6M | 74.6M | |
| Other Current Assets | 131.0M | 1.1B | 46.5M | 840.4M | 966.5M | 613.4M | |
| Total Liab | 2.3B | 2.3B | 3.7B | 1.5B | 1.7B | 2.2B | |
| Total Current Assets | 1.2B | 1.7B | 3.6B | 1.1B | 1.3B | 1.8B | |
| Short Term Debt | 437.6M | 155M | 312.3M | 311.0M | 357.7M | 268.3M | |
| Intangible Assets | 152.2M | 337.0M | 105.0M | 93.2M | 107.2M | 155.3M |
NeueHealth Key Income Statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Revenue | 514.9M | 1.5B | 751.2M | 1.2B | 1.3B | 928.5M | |
| Gross Profit | 63.0M | 218.9M | 88.2M | 164.2M | 147.8M | 130.4M | |
| Operating Income | (170.4M) | (343.6M) | (368.8M) | (577.0M) | (519.3M) | (493.3M) | |
| Ebit | (257.6M) | (343.6M) | (277.1M) | (585.1M) | (526.6M) | (500.3M) | |
| Ebitda | (249.3M) | (308.6M) | (246.4M) | (566.8M) | (510.1M) | (484.6M) | |
| Income Before Tax | (170.4M) | (349.6M) | (381.6M) | (629.2M) | (566.3M) | (537.9M) | |
| Net Income | (248.4M) | (1.2B) | (1.5B) | (1.2B) | (1.0B) | (1.1B) |
NeueHealth Key Cash Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | (34.5M) | 572.8M | 871.1M | (1.6B) | (1.4B) | (1.3B) | |
| Free Cash Flow | (63.7M) | 51.6M | 207.0M | (2.7B) | (2.5B) | (2.3B) | |
| Depreciation | 8.3M | 35.5M | 50.6M | 24.2M | 27.8M | 26.3M | |
| Other Non Cash Items | 2.7M | (60.0M) | 272.0M | 477.4M | 549.1M | 576.5M | |
| Capital Expenditures | 6.5M | 30.4M | 27.4M | 2.9M | 3.3M | 3.2M | |
| Net Income | (248.4M) | (1.2B) | (1.4B) | (1.2B) | (1.0B) | (1.1B) | |
| End Period Cash Flow | 488.4M | 1.1B | 1.9B | 375.3M | 431.6M | 410.0M |
NeueHealth Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining NeueHealth's current stock value. Our valuation model uses many indicators to compare NeueHealth value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across NeueHealth competition to find correlations between indicators driving NeueHealth's intrinsic value. More Info.NeueHealth is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . At present, NeueHealth's Return On Equity is projected to increase slightly based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value NeueHealth by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.NeueHealth Systematic Risk
NeueHealth's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. NeueHealth volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on NeueHealth correlated with the market. If Beta is less than 0 NeueHealth generally moves in the opposite direction as compared to the market. If NeueHealth Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one NeueHealth is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of NeueHealth is generally in the same direction as the market. If Beta > 1 NeueHealth moves generally in the same direction as, but more than the movement of the benchmark.
NeueHealth Thematic Clasifications
NeueHealth is part of Insurance investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Insurance industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
This theme covers USA Equities from Insurance industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
| Insurance | View |
Today, most investors in NeueHealth Stock are looking for potential investment opportunities by analyzing not only static indicators but also various NeueHealth's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of NeueHealth growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
NeueHealth March 19, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of NeueHealth help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of NeueHealth. We use our internally-developed statistical techniques to arrive at the intrinsic value of NeueHealth based on widely used predictive technical indicators. In general, we focus on analyzing NeueHealth Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build NeueHealth's daily price indicators and compare them against related drivers.
| Downside Deviation | 5.62 | |||
| Information Ratio | 0.0251 | |||
| Maximum Drawdown | 98.32 | |||
| Value At Risk | (8.27) | |||
| Potential Upside | 1.38 |
Complementary Tools for NeueHealth Stock analysis
When running NeueHealth's price analysis, check to measure NeueHealth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeueHealth is operating at the current time. Most of NeueHealth's value examination focuses on studying past and present price action to predict the probability of NeueHealth's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeueHealth's price. Additionally, you may evaluate how the addition of NeueHealth to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |